Recent Transactions

01-May-13
$NA
Australia flag
Target: 

Jeminex’s Industrial & Safety division

United Kingdom flag
Acquiror: 
Bunzl plc

Advised AMP Capital on the sale of Jeminex’s Industrial & Safety division, Australia’s second largest industrial and safety business with branches across Australia, to Bunzl plc

26-Apr-13
$313 million
Belgium flag
Target: 

Azelis S.A.

Advised Azelis S.A., a Pan-European distributor of specialty chemicals owned by funds managed by 3i plc, on its covenant reset and a two year maturity extension of its €240mm syndicated debt package

07-Dec-12
$43 million
New Zealand flag
Target: 

Champion Flour Limited

Japan flag
Acquiror: 
Nisshin Seifun Group Inc.

Advised Goodman Fielder, a leading Australian listed food company, on the sale of its New Zealand flour milling business, Champion Flour, to Nisshin Seifun Group Inc.

23-Nov-12
$NA
Sweden flag
Target: 

SAS Group

Norway flag
Acquiror: 
Norwegian Government

Advised the Norwegian Government in relation to some specific issues in connection with the restructuring of SAS, the leading airline group in Northern Europe

20-Sep-12
$1.0 billion
United States flag
Target: 

Becker Underwood

Germany flag
Acquiror: 
BASF

Advised Norwest Equity Partners on the sale of its portfolio company Becker Underwood, a global leader in the development and commercialization of yield-improving seed-applied biological products for the Agricultural market, to BASF, the world’s largest chemical company

01-Aug-12
$4.0 billion
South Africa, Switzerland flags
Target: 

Mediclinic International Limited

Advised Mediclinic International, South Africa’s second largest and Switzerland’s largest provider of private hospital services, on the restructuring of its entire balance sheet, including $2.2 billion debt refinancing in Switzerland and a $0.6 billion rights issue in South Africa

01-Mar-12
$NA
Switzerland flag
Target: 

Minority stake in Stadler Rail

Switzerland flag
Acquiror: 
Peter Spuhler

Advised Capvis, one of the leading buyout firms in Switzerland and one of the main mid-market private equity firms in German-speaking Europe, on the staged exit from of its 20% minority stake in Stadler Rail, by selling to Peter Spuhler, CEO and majority shareholder in Stadler Rail

30-Jun-11
$609 million
Japan flag
Target: 

Diabetes-related patent estate and royalty stream of Astellas Pharma subsidiary, Prosidion

United States flag
Acquiror: 
Royalty Pharma

Advised Royalty Pharma, a leading acquiror of biopharmaceutical royalty interests, on the acquisition of the DPP-IV patent estate and associated royalty stream of Astellas Pharma subsidiary, Prosidion

22-Jun-11
$NA
Finland flag
Target: 

KemFine Group Oy

Germany flag
Acquiror: 
CABB AG

Advised 3i on the disposal of KemFine Group Oy, a leading custom manufacturer of fine chemicals, to CABB AG

15-Jan-11
$105 million
Germany flag
Target: 

telerob Holding GmbH

United Kingdom flag
Acquiror: 
Cobham plc

Advised the shareholders of telerob Holding GmbH, a German-based market leader in the development and manufacture of advanced bomb disposal robots and integrated threat response vehicles, on the sale of the Company to Cobham plc, the UK-based, internationally operating aerospace, defence and security technology group

15-Dec-10
$12.9 billion
U.S.A., Swiss flags
Target: 

Alcon, Inc.

Switzerland flag
Acquiror: 
Novartis AG

Advised the Independent Director Committee of Alcon, Inc., an ophthalmic pharmaceutical company, on the sale of Alcon’s outstanding publicly held interest to Novartis AG, a global pharmaceutical company

13-Dec-10
$256 million
United Kingdom flag
Target: 

Maxinutrition Group Holdings Limited

United Kingdom flag
Acquiror: 
GlaxoSmithKline Plc

Advised GlaxoSmithKline Plc, the UK listed international pharmaceutical and consumer company, on its acquisition of Maxinutrition Group Holdings Limited, a UK based sports nutrition business, from Darwin Private Equity

01-Dec-10
$100 million
United Kingdom flag
Target: 

Clyde Process Solutions plc

Germany flag
Acquiror: 
S-Process Equipment International S.à r.l. (Schenck Process)

Advised S-Process Equipment International S.à r.l. (“Schenck Process”), a global leader in bulk material handling, providing applications incorporating weighing, feeding, screening and automation solutions, on its acquisition of Clyde Process Solutions plc, a global provider of pneumatic conveying and air filtration solutions for process industries

01-Dec-10
$NA
United States flag
Target: 

Planar Solutions, LLC

Japan flag
Acquiror: 
FUJIFILM Corporation

Advised Wacker Chemie AG on the sale of Wacker Chemical Corporation’s 50% equity stake in Planar Solutions LLC, a dedicated CMP slurry manufacturer, to its JV partner, FUJIFILM Corporation

26-Nov-10
$118 million
Australia flag
Target: 

Healthcare Australia

United Kingdom flag
Acquiror: 
Healthcare Locums

Advised CHAMP Private Equity on the sale of Healthcare Australia, a leading provider of nursing agency staff to public and private health institutions in Australia, to Healthcare Locums, a healthcare recruitment agency based in the UK

16-Sep-10
$NA
United Kingdom flag
Target: 

KemFine UK Ltd

Germany flag
Acquiror: 
AURELIUS AG

Advised KemFine Group Oy, a 3i portfolio company, on the sale of its UK-based fine chemicals business, KemFine UK Ltd, to AURELIUS AG

28-Jun-10
$336 million
United Kingdom flag
Target: 

Scott Wilson Group plc

United States flag
Acquiror: 
URS Corporation

Advised Scott Wilson Group plc, a LSE listed global integrated design and engineering consultancy, on its sale to URS Corporation, a global provider of engineering, construction and technical services

26-Apr-10
$1.5 billion
United Kingdom flag
Target: 

Chloride Group plc

United States flag
Acquiror: 
Emerson Electric Co.

Advised Emerson Electric Co., a diversified global technology and industrial company, on its acquisition of Chloride Group plc, a manufacturer of uninterruptible power supply (UPS) systems

09-Nov-09
$327 million
United States flag
Target: 

Enzon Pharmaceuticals, Inc.

Italy flag
Acquiror: 
Sigma-Tau Pharmaceuticals

Advised Enzon Pharmaceuticals, Inc., a biopharmaceutical company on the sale of its specialty pharmaceutical business to Sigma-Tau, an Italian pharmaceutical company

29-Jul-09
$573 million
United Kingdom flag
Target: 

Rexam plc

Acted as Financial Adviser and Joint Sponsor to Rexam plc, a leading global consumer packaging group, on its rights issue

16-Jul-09
$NA
United Kingdom flag
Target: 

Pension Trustees of Galiform PLC

Advised the Pension Trustees of the Galiform PLC Defined Benefit Pension Scheme to negotiate a revised schedule of payments to fund its deficit

05-Jul-09
$1.2 billion
United Kingdom flag
Target: 

Alcan Packaging’s Food Americas business (business unit of Rio Tinto plc)

United States flag
Acquiror: 
Bemis Company, Inc.

Advised Bemis Company, Inc., a global supplier of flexible packaging and pressure sensitive materials, on its acquisition of Alcan Packaging’s Food Americas business

19-Mar-09
$349 million
United Kingdom flag
Target: 

Inchcape plc

Provided financial advice to Inchcape, the leading independent international automotive retailer, on its assessment of funding and strategic options, resulting in a significant rights issue to strengthen the balance sheet

12-Mar-09
$46.9 billion
United States flag
Target: 

Genentech, Inc.

Switzerland flag
Acquiror: 
Roche Holding Ltd.

Advised Roche Holding Ltd., a world-leading provider of healthcare pharmaceuticals and diagnostics, on its acquisition of the outstanding publicly held interest in Genentech, Inc., a leading biotechnology company

12-Oct-08
$6.0 billion
Germany flag
Target: 

Hapag-Lloyd AG

Germany flag
Acquiror: 
Albert Ballin KG

Advised TUI AG, Europe’s largest tourism company, on its sale of its shipping division Hapag-Lloyd AG, one of the leading global container shipping companies

Pages

show all